Tekla Life Sciences Investors (HQL)
$18.15+4.13%Close
SELLBEAR · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $552M
- Beta
- 0.72
- Div yield
- 12.76%
- P/E (TTM)
- 2.60
- Short % float
- 0.41%
- Days to cover
- 1.0
- SI change
- +67.3%
- 1W
- +2.66%
- 1M
- -8.29%
- vs SPY 1W
- +1.50%
- vs SPY 1M
- -11.28%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on HQL?
- LOPJLB’s latest quantitative signal on Tekla Life Sciences Investors (HQL) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is HQL in?
- Tekla Life Sciences Investors (HQL) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Tekla Life Sciences Investors (HQL) do?
- Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a …